Serum-derived exosomes of HER2 as a promising biomarker for advanced gastric cancer had an area under the ROC curve of 0.746, a sensitivity of 66.7% and a specificity of 74.2% (83). The gene discussed is ERBB2; the disease is gastric cancer.